Gb3-binding lectins as potential carriers for transcellular drug delivery

References

• Rodriguez-Boulan E, Kreitzer G, Müsch A. Organization of vesicular trafficking in epithelia. Nat Rev Mol Cell Biol. 2005;6(3):233–247.
   PubMed Web of Science ®Google Scholar
• Thuenauer R, Müller S, Römer W. Pathways of protein and lipid receptor-mediated transcytosis in drug delivery. Expert Opin Drug Deliv. 2016;1–11. doi:10.1080/17425247.2016.1220364. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRX. 2005;2(1):3–14.
   PubMedGoogle Scholar
• Fischer H, Gottschlich R, Seelig A. Blood-brain barrier permeation: molecular parameters governing passive diffusion. J Membr Biol. 1998;165(3):201–211.
   PubMed Web of Science ®Google Scholar
• Coloma MJ, Lee HJ, Kurihara A, et al. Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor. Pharm Res. 2000;17(3):266–274.
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu L. Modern methods for delivery of drugs across the blood-brain barrier. Adv Drug Deliv Rev. 2012;64(7):640–665.
   PubMed Web of Science ®Google Scholar
• Niewoehner J, Bohrmann B, Collin L, et al. Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle. Neuron. 2014;81(1):49–60.
   PubMed Web of Science ®Google Scholar
• Qian ZM, Li H, Sun H, et al. Delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev. 2002;54(4):561–587.
   PubMed Web of Science ®Google Scholar
• Wu D, Yang J, Pardridge WM. Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor. J Clin Invest. 1997;100(7):1804–1812.
   PubMed Web of Science ®Google Scholar
• Sade H, Baumgartner C, Hugenmatter A, et al. A human blood-brain barrier transcytosis assay reveals antibody transcytosis influenced by pH-dependent receptor binding. PLoS One. 2014;9(4):e96340.
   PubMed Web of Science ®Google Scholar
• van Genderen I, van Meer G. Differential targeting of glucosylceramide and galactosylceramide analogues after synthesis but not during transcytosis in Madin-Darby canine kidney cells. J Cell Biol. 1995;131(3):645–654.
   PubMed Web of Science ®Google Scholar
• Simons K, van Meer G. Lipid sorting in epithelial cells. Biochemistry. 1988;27(17):6197–6202.
   PubMed Web of Science ®Google Scholar
• Schubert T, Römer W. How synthetic membrane systems contribute to the understanding of lipid-driven endocytosis. Biochim Biophys Acta Mol Cell Res. 2015;1853(11):2992–3005.
   PubMed Web of Science ®Google Scholar
• Römer W, Berland L, Chambon V, et al. Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature. 2007;450(7170):670–675.
   PubMed Web of Science ®Google Scholar
• Römer W, Pontani -L-L, Sorre B, et al. Actin dynamics drive membrane reorganization and scission in clathrin-independent endocytosis. Cell. 2010;140(4):540–553.
   PubMed Web of Science ®Google Scholar
• Ewers H, Römer W, Smith AE, et al. GM1 structure determines SV40-induced membrane invagination and infection. Nat Cell Biol. 2010;12(1):11–18.
   PubMed Web of Science ®Google Scholar
• Chinnapen DJF, Hsieh WT, Te Welscher YM, et al. Lipid sorting by ceramide structure from plasma membrane to ER for the cholera toxin receptor ganglioside GM1. Dev Cell. 2012;23(3):573–586.
   PubMed Web of Science ®Google Scholar
• Okuda T, Tokuda N, Numata SI, et al. Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins. J Biol Chem. 2006;281(15):10230–10235.
   PubMed Web of Science ®Google Scholar
• Eisenhauer PB, Chaturvedi P, Fine RE, et al. Tumor necrosis factor alpha increases human cerebral endothelial cell Gb 3 and sensitivity to Shiga Toxin. Infect Immun. 2001;69(3):1889–1894.
   PubMed Web of Science ®Google Scholar
• Meisen I, Rosenbrück R, Galla HJ, et al. Expression of Shiga toxin 2e glycosphingolipid receptors of primary porcine brain endothelial cells and toxin-mediated breakdown of the blood-brain barrier. Glycobiology. 2013;23(6):745–759.
   PubMed Web of Science ®Google Scholar
• Legros N, Dusny S, Humpf H-U, et al. Shiga toxin glycosphingolipid receptors and their lipid membrane ensemble in primary human blood–brain barrier endothelial cells. Glycobiology. 2016. Available from: https://doi.org/10.1093/glycob/cww090. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Ling H, Boodhoo A, Hazes B, et al. Structure of the Shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. Biochemistry. 1998;37(7):1777–1788.
   PubMed Web of Science ®Google Scholar
• Cioci G, Mitchell EP, Gautier C, et al. Structural basis of calcium and galactose recognition by the lectin PA-IL of Pseudomonas aeruginosa. FEBS Lett. 2003;555(2):297–301.
   PubMed Web of Science ®Google Scholar
• Kandel G, Donohue-Rolfe A, Donowitz M, et al. Pathogenesis of Shigella diarrhea. XVI. Selective targetting of Shiga toxin to villus cells of rabbit jejunum explains the effect of the toxin on intestinal electrolyte transport. J Clin Invest. 1989;84(5):1509–1517.
   PubMed Web of Science ®Google Scholar
• Lanne B, Ciopraga J, Bergstrom J, et al. Binding of the galactose-specific Pseudomonas aeruginosa lectin, PA-I, to glycosphingolipids and other glycoconjugates. Glycoconj J. 1994;11(4):292–298.
   PubMed Web of Science ®Google Scholar
• Blanchard B, Nurisso A, Hollville E, et al. Structural basis of the preferential binding for globo-series glycosphingolipids displayed by Pseudomonas aeruginosa lectin I. J Mol Biol. 2008;383(4):837–853.
   PubMed Web of Science ®Google Scholar
• Mallard F, Antony C, Tenza D, et al. Direct pathway from early/recycling endosomes to the golgi apparatus revealed through the study of Shiga Toxin B-fragment transport. J Cell Biol. 1998;143(4):973–990.
   PubMed Web of Science ®Google Scholar
• McKenzie JE, Raisley B, Zhou X, et al. Retromer guides STxB and CD8-M6PR from early to recycling endosomes, EHD1 guides STxB from recycling endosome to Golgi. Traffic. 2012;13(8):1140–1159.
   PubMed Web of Science ®Google Scholar
• Eierhoff T, Bastian B, Thuenauer R, et al. A lipid zipper triggers bacterial invasion. Proc Natl Acad Sci. 2014;111(35):12895–12900.
   PubMed Web of Science ®Google Scholar
• Wang Q, Rager JD, Weinstein K, et al. Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier. Int J Pharm. 2005;288(2):349–359.
   PubMed Web of Science ®Google Scholar
• Garberg P, Ball M, Borg N, et al. In vitro models for the blood-brain barrier. Toxicol In Vitro. 2005;19(3):299–334.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Boulan E, Macara IG. Organization and execution of the epithelial polarity programme. Nat Rev Mol Cell Biol. 2014;15(4):225–242.
   PubMed Web of Science ®Google Scholar
• Goldenring JR. Recycling endosomes. Curr Opin Cell Biol. 2015;35:117–122.
   PubMed Web of Science ®Google Scholar
• Bryant DM, Mostov KE. From cells to organs: building polarized tissue. Nat Rev Mol Cell Biol. 2008;9(11):887–901.
   PubMed Web of Science ®Google Scholar
• Imberty A, Wimmerová M, Mitchell EP, et al. Structures of the lectins from Pseudomonas aeruginosa: insights into the molecular basis for host glycan recognition. Microbes Infect. 2004;6(2):221–228.
   PubMed Web of Science ®Google Scholar
• Thuenauer R, Hsu Y, Carvajal-Gonzalez JM, et al. Four-dimensional live imaging of apical biosynthetic trafficking reveals a post-Golgi sorting role of apical endosomal intermediates. Proc Natl Acad Sci. 2014;111(11):4127–4132.
   PubMed Web of Science ®Google Scholar
• Zinchuk V, Zinchuk O, Okada T. Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: pushing pixels to explore biological phenomena. Acta Histochem Cytochem. 2007;40(4):101–111.
   PubMed Web of Science ®Google Scholar
• Su T, Bryant DM, Luton F, et al. A kinase cascade leading to Rab11-FIP5 controls transcytosis of the polymeric immunoglobulin receptor. Nat Cell Biol. 2010;12(12):1143–1153.
   PubMed Web of Science ®Google Scholar
• Vergés M, Sebastián I, Mostov KE. Phosphoinositide 3-kinase regulates the role of retromer in transcytosis of the polymeric immunoglobulin receptor. Exp Cell Res. 2007;313(4):707–718.
   PubMed Web of Science ®Google Scholar
• Mostov KE, Deitcher DL. Polymeric immunoglobulin MDCK cells transcytoses receptor IgA expressed in MDCK cells transcytoses IgA. Cell. 1986;46(4):613–621.
   PubMed Web of Science ®Google Scholar
• Warnier M, Römer W, Geelen J, et al. Trafficking of Shiga toxin/Shiga-like toxin-1 in human glomerular microvascular endothelial cells and human mesangial cells. Kidney Int. 2006;70(12):2085–2091.
   PubMed Web of Science ®Google Scholar
• Falguieres T, Mallard F, Baron C, et al. Targeting of Shiga Toxin B-Subunit to retrograde transport route in association with detergent-resistant membranes. Mol Biol Cell. 2001;12(8):2453–2468.
   PubMed Web of Science ®Google Scholar
• Wilson JM, de Hoop M, Zorzi N, et al. EEA1, a tethering protein of the early sorting endosome, shows a polarized distribution in hippocampal neurons, epithelial cells, and fibroblasts. Mol Biol Cell. 2000;11(8):2657–2671.
   PubMed Web of Science ®Google Scholar
• Mallard F, Tang BL, Galli T, et al. Early/recycling endosomes-to-TGN transport involves two SNARE complexes and a Rab6 isoform. J Cell Biol. 2002;156(4):653–664.
   PubMed Web of Science ®Google Scholar
• Sheff DR, Daro EA, Hull M, et al. The receptor recycling pathway contains two distinct populations of early endosomes with different sorting functions. J Cell Biol. 1999;145(1):123–139.
   PubMed Web of Science ®Google Scholar
• Golachowska MR, Hoekstra D, van Ijzendoorn SCD. Recycling endosomes in apical plasma membrane domain formation and epithelial cell polarity. Trends Cell Biol. 2010;20(10):618–626.
   PubMed Web of Science ®Google Scholar
• Apodaca G, Katz LA, Mostov KE. Receptor-mediated transcytosis of IgA in MDCK cells is via apical recycling endosomes. J Cell Biol. 1994;125(1):67–86.
   PubMed Web of Science ®Google Scholar
• Laiko M, Murtazina R, Malyukova I, et al. Shiga toxin 1 interaction with enterocytes causes apical protein mistargeting through the depletion of intracellular galectin-3. Exp Cell Res. 2010;316(4):657–666.
   PubMed Web of Science ®Google Scholar
• Johannes L, Römer W. Shiga toxins–from cell biology to biomedical applications. Nat Rev Microbiol. 2010;8(2):105–116.
   PubMed Web of Science ®Google Scholar
• Banks WA. Characteristics of compounds that cross the blood-brain barrier. BMC Neurol. 2009;9(1):S3.
   PubMed Web of Science ®Google Scholar
• Lingwood CA, Binnington B, Manis A, et al. Globotriaosyl ceramide receptor function - Where membrane structure and pathology intersect. FEBS Lett. 2010;584(9):1879–1886.
   PubMed Web of Science ®Google Scholar
• Lingwood D, Ries J, Schwille P, et al. Plasma membranes are poised for activation of raft phase coalescence at physiological temperature. Proc Natl Acad Sci. 2008;105(29):10005–10010.
   PubMed Web of Science ®Google Scholar
• Saslowsky DE, Te Welscher YM, Chinnapen DJ-F, et al. Ganglioside GM1-mediated transcytosis of cholera toxin bypasses the retrograde pathway and depends on the structure of the ceramide domain. J Biol Chem. 2013;288(36):25804–25809.
   PubMed Web of Science ®Google Scholar
• Huwyler J, Wu D, Pardridge WM. Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci. 1996;93(24):14164–14169.
   PubMed Web of Science ®Google Scholar
• Juillerat-Jeanneret L. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles? Drug Discov Today. 2008;13(23–24):1099–1106.
   PubMed Web of Science ®Google Scholar
• Jayagopal A, Sussman EM, Shastri VP. Functionalized solid lipid nanoparticles for transendothelial delivery. IEEE Trans Nanobioscience. 2008;7(1):28–34.
   PubMed Web of Science ®Google Scholar
• Reents R, Jeyaraj DA, Waldmann H. Enzymatically cleavable linker groups in polymer-supported synthesis. Drug Discov Today. 2002;7(1):71–76.
   PubMed Web of Science ®Google Scholar
• Dubowchik GM, Walker MA. Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs. Pharmacol Ther. 1999;83(2):67–123.
   PubMed Web of Science ®Google Scholar
• Arnaud J, Claudinon J, Tröndle K, et al. Reduction of lectin valency drastically changes glycolipid dynamics in membranes but not surface avidity. ACS Chem Biol. 2013;8(9):1918–1924.
   PubMed Web of Science ®Google Scholar
• Arnaud J, Tröndle K, Claudinon J, et al. Membrane deformation by neolectins with engineered glycolipid binding sites. Angew Chemie. 2014;53(35):9267–9270.
   PubMed Web of Science ®Google Scholar